Skip to content
Save up to 80% Fast & Discrete Delivery
Avodart
Quality products
Fast & Discrete Delivery
Money-back guarantee

Avodart

3.9 (5 customer reviews)
Delivery: 4-7 business days
Payment
24/7 Support
Active ingredient: Dutasteride

Free bonus tablets with every order: 4 on any order, 8 over $112.00, 12 over $222.88, 16 over $334.88

256-bit SSL
Certified pharmacy
Money-back guarantee

For adult men diagnosed with benign prostatic hyperplasia (BPH), Avodart contains dutasteride to reduce the hormonal drive behind prostate enlargement. Its oral capsules lower dihydrotestosterone (DHT), which can gradually improve urinary flow and reduce the risk of urinary retention linked to an enlarged prostate.

Overview

Avodart is an oral dutasteride product for adult men with benign prostatic hyperplasia. It belongs to the 5-alpha-reductase inhibitor class and reduces conversion of testosterone into dihydrotestosterone.

Therapeutic indications

BPH is noncancerous enlargement of the prostate gland. As the prostate grows around the urethra, it can weaken the urine stream, delay starting urination, cause frequent nighttime urination, or leave a feeling that the bladder has not emptied.

Avodart is used for BPH because lowering DHT reduces hormonal stimulation inside prostate tissue. Over time, reduced prostate volume can relieve lower urinary tract symptoms and lower the chance of acute urinary retention, a painful inability to pass urine.

Clinical management of lower urinary tract symptoms

Symptom improvement is gradual. Men often notice that urgency, weak flow, and nighttime trips do not change in the first days of treatment because the prostate needs time to respond.

Clinical guidelines from the American Urological Association support 5-alpha-reductase inhibitors for men with lower urinary tract symptoms and demonstrable prostate enlargement, especially when reducing progression risk is a treatment goal [2].

A symptom diary can be useful during the first months: record nighttime urination, urgency episodes, and whether the urine stream feels stronger. Small changes are easier to recognize when written down.

Avodart can lower prostate-specific antigen, or PSA, by about half after sustained treatment. A clinician interpreting future PSA results needs to know that dutasteride is being used, because a rising PSA while on treatment may need assessment.

How it affects the body

Dutasteride blocks 5-alpha-reductase, the enzyme that converts testosterone into dihydrotestosterone. DHT has a stronger effect than testosterone on prostate growth, so reducing DHT slows the biological signal that maintains an enlarged prostate.

Inhibition of type 1 and type 2 isoenzymes

The body has type 1 and type 2 5-alpha-reductase isoenzymes. Dutasteride inhibits both forms, while some related treatments primarily inhibit type 2.

This dual action produces marked suppression of serum DHT levels. Testosterone does not disappear; less of it is converted into DHT. The mechanism explains both the urinary benefits and the possibility of sexual adverse effects.

A Cochrane review found that dutasteride improves urinary symptoms and reduces BPH progression outcomes over longer treatment periods, with sexual adverse effects occurring more often than with placebo [3].

Reasons not to use it

It is also unsuitable for people with a known allergy to dutasteride, other 5-alpha-reductase inhibitors, or capsule ingredients.

Use needs careful review in these situations:

  • Significant liver disease, because dutasteride is metabolized in the liver.
  • Use of strong CYP3A4 inhibitors, including ketoconazole, ritonavir, and certain macrolide antibiotics, which may raise dutasteride exposure.
  • Planned blood donation, because dutasteride can remain in the bloodstream for an extended period.
  • Evaluation for prostate cancer, because dutasteride changes PSA interpretation.
  • Attempts to conceive, due to possible effects on semen characteristics.

When this is not for you

Avodart is not for you if you are pregnant, may become pregnant, or could be exposed to leaking capsule contents during pregnancy. Dutasteride can interfere with development of the external genitalia of a male fetus.

Women who are pregnant or could become pregnant should not handle leaking Avodart capsules. Intact capsules can be handled normally.

Possible side effects

Avodart is usually tolerated, though sexual effects are the main limitation for some men. Reported adverse effects include decreased libido, erectile dysfunction, reduced semen volume, ejaculation disorders, and breast tenderness or enlargement.

In clinical trials, sexual adverse effects were most often reported during the earlier months of therapy and became less frequent over time for many men. They can still persist in some individuals after treatment ends.

A small number of people report mood changes. The EMA reviewed evidence on suicidal thoughts associated with finasteride and dutasteride medicines in 2024 and advises attention to new depression or mood symptoms during treatment [4].

If breast lumps, nipple discharge, persistent breast pain, or a new depressed mood develops, arrange a clinical review rather than assuming the symptom will pass on its own.

Dutasteride can also reduce semen parameters. This matters for men trying to conceive, even though fertility effects may improve after treatment is stopped.

Formulation

Avodart contains dutasteride, a dual 5-alpha-reductase inhibitor supplied as an oral capsule. This drug class targets the enzyme that converts testosterone into DHT, a potent androgen involved in prostate growth.

Active ingredient and formulation

Dutasteride is the active constituent in Avodart. The capsule is swallowed whole and is designed for regular oral use rather than rapid symptom relief.

Dutasteride does not relax prostate muscle immediately. Its benefit develops as DHT falls and prostate tissue slowly becomes smaller.

Swallow Avodart capsules whole. Do not open, crush, or chew them, because the capsule contents can irritate the mouth and throat.

The FDA prescribing information identifies dutasteride as a 5-alpha-reductase inhibitor for symptomatic BPH in men with an enlarged prostate [1].

Dosage and administration

  • Take Avodart orally as a capsule.
  • The amount per intake is set individually rather than being one fixed dose.
  • Use it at the individually prescribed frequency and time of day; meal timing is not established in the available information.
  • Continue for the duration determined for management of benign prostatic hyperplasia, as symptom improvement is gradual.

Comparison

Dutasteride and finasteride both reduce DHT, yet they differ in enzyme selectivity and how long they remain in the body. Finasteride is also marketed under the name Propecia for male pattern hair loss, while Avodart contains dutasteride.

Feature Avodart: dutasteride Finasteride
Enzyme inhibition Type 1 and type 2 5-alpha-reductase Mainly type 2 5-alpha-reductase
DHT reduction Greater suppression of circulating DHT Lower suppression of circulating DHT
Terminal elimination About 4–5 weeks About 5–6 hours

Dutasteride’s longer half-life means its effects fade slowly after stopping. This can be helpful for stable DHT suppression, though it also means adverse effects may not resolve immediately.

Finasteride may be selected when type 2 inhibition is sufficient for the treatment goal. Dutasteride may be preferred for BPH with a clearly enlarged prostate because dual enzyme inhibition produces stronger DHT suppression.

Common mistakes

  • Expecting a dramatic urinary change within the first week.
  • Stopping after a short trial because the prostate has not yet had time to shrink.
  • Taking capsules intermittently, then judging the treatment from inconsistent use.
  • Forgetting to mention Avodart before a PSA blood test.
  • Opening a capsule because it seems difficult to swallow.
  • Assuming a weaker urine stream always means the dose should be changed.
A sudden inability to urinate, fever with urinary symptoms, visible blood in urine, or severe lower abdominal pain needs prompt medical assessment. These symptoms are not problems to manage by taking an extra capsule.

What doctors say

In urology practice, Avodart is often chosen for the man whose BPH is linked to genuine prostate enlargement rather than urinary symptoms alone. A clinician usually sets expectations early: this treatment addresses prostate biology gradually, not the next morning’s urine flow.

The strongest benefit is often prevention. Reduced progression, less risk of urinary retention, and a lower likelihood of needing BPH-related surgery can matter as much as day-to-day symptom change.

Doctors also watch PSA trends rather than relying on one isolated result. A stable, adjusted PSA pattern can be reassuring; a meaningful rise deserves attention even when the absolute value appears modest.

Common questions

What happens if I stop Avodart, and do I need to taper it?

Dutasteride does not usually require tapering because it is not associated with withdrawal symptoms. Its long elimination half-life means DHT suppression and prostate-related effects fade gradually rather than ending abruptly. The FDA prescribing information published in 2011 describes a prolonged persistence of dutasteride in the body, which explains why effects can continue after the last capsule. Symptoms of BPH may slowly return if the underlying prostate enlargement progresses.

How long does an Avodart course last, and can it be used long term?

Avodart is commonly used as ongoing therapy when BPH symptoms and prostate size support continued treatment. There is no fixed short course for prostate shrinkage, since the treatment goal often includes lowering future retention and surgery risk. The American Urological Association guideline amendment from 2023 supports long-term 5-alpha-reductase inhibitor therapy for appropriate men with enlarged prostates. Treatment should be reviewed through urinary symptoms, tolerability, and PSA monitoring.

How soon does Avodart start to work?

DHT levels fall soon after treatment starts, but urinary improvement can take several months because prostate shrinkage is gradual. The Cochrane review published in 2010 found that dutasteride outcomes are most meaningful when assessed over longer treatment periods. A person may notice less urgency or fewer nighttime bathroom visits before a clear improvement in urine stream. Persistent symptoms during the early phase do not automatically mean treatment failure.

Which concrete condition rules out Avodart use?

Pregnancy rules out Avodart use because dutasteride may affect normal development of male fetal genitalia. The FDA warning from 2011 also advises that people who are pregnant or may become pregnant avoid contact with leaking capsules. This precaution applies even though Avodart is prescribed for adult men. Intact capsules should remain sealed and handled normally. A pharmacist can clarify handling questions.

How should Avodart be stored at home and while traveling?

Keep Avodart capsules dry, away from excess heat, and out of reach of children. The FDA product information published in 2011 advises storage at controlled room temperature and protection from conditions that could damage the soft gelatin capsule. During travel, keep capsules in a closed container rather than a hot vehicle or direct sunlight. Do not use capsules that are leaking, misshapen, or softened by heat.

Can Avodart cause erectile dysfunction?

Yes, erectile dysfunction is a documented potential adverse effect of dutasteride. The FDA clinical safety data from 2011 list erectile dysfunction, decreased libido, and ejaculation disorders among the more frequent adverse reactions. Risk differs between individuals, and some men find these effects lessen with continued treatment. A persistent change in erectile function deserves a clinical discussion, especially when it affects quality of life.

What should I do if Avodart does not produce the expected result?

Allow enough time for the biological effect before deciding that Avodart has failed, since prostate reduction is slow. The American Urological Association guideline from 2023 recognizes that symptom severity may require reassessment for bladder dysfunction, infection, stones, medication effects, or another urologic cause. Alpha-blocker therapy or another management approach may be considered when faster symptom relief is needed. A sudden worsening of urine flow needs assessment rather than self-adjusting the dose.

Do you offer anonymous delivery?

Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in.) and its contents cannot be seen.

Comparison

Comparison table: Benign Prostatic Hyperplasia

Customer Feedback on Avodart

Neil, 64
New York
Several months
Verified
Rating: 5 out of 5
New York, I used Avodart for BPH-related nighttime urination for several months. By the fourth month, I was getting up less often and my urine stream felt more reliable. The slow start was frustrating, but the gradual improvement was clear.
Nov 3, 2026
Darren, 58
San Diego
A few months
Verified
Rating: 3.5 out of 5
San Diego, I took Avodart for an enlarged prostate and noticed less urgency after a few months. During the first weeks, my libido was lower, then it became less noticeable. The improvement was real, but it took more patience than I expected.
Nov 9, 2026
Liam N., 44
Raleigh
Verified
Rating: 4 out of 5
Raleigh, I used Avodart after persistent urinary flow problems linked to prostate enlargement. The stream became stronger over time, and I stopped planning every outing around finding a restroom. It was a quiet improvement rather than a dramatic one.
Oct 12, 2026
Daniel, 64
Nashville
Several months
Verified
Rating: 3 out of 5
Nashville, I had fewer nighttime bathroom trips after several months, but ejaculation changes bothered me. I discussed it during a follow-up and decided the urinary improvement was worth continuing. The result was useful, though there was a trade-off.
Oct 21, 2026
Thomas, 42
San Antonio
Verified
Rating: 4 out of 5
San Antonio, I started Avodart because an enlarged prostate was affecting my sleep and workdays. After sticking with it, I was waking less often and felt less pressure during urination. The longer timeline made sense once I saw the change.
Nov 1, 2026

Sources

  1. FDA (2011). Avodart (dutasteride) Prescribing Information.
  2. American Urological Association (2023). Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2023.
  3. Cochrane Database of Systematic Reviews (2010). Dutasteride for the treatment of benign prostatic hyperplasia.
  4. EMA (2024). Measures to minimise risk of suicidal thoughts with finasteride and dutasteride medicines.
Get our free app Shop faster and track your orders 4.0 · 266 reviews Install